Adaptimmune Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ADAPY and buy or sell other stocks, ETFs, and their options commission-free!About ADAPY
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.
CEOChristopher James Hill
CEOChristopher James Hill
Employees506
Employees506
HeadquartersAbingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded2014
Founded2014
Employees506
Employees506
ADAPY Key Statistics
Market cap8.72M
Market cap8.72M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume785.01K
Average volume785.01K
High today$0.0339
High today$0.0339
Low today$0.0268
Low today$0.0268
Open price$0.03
Open price$0.03
Volume169.25K
Volume169.25K
52 Week high$0.3578
52 Week high$0.3578
52 Week low$0.0001
52 Week low$0.0001
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.